Anti-Human IL5RA Recombinant Antibody_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human IL5RA Recombinant Antibody

Anti-Human IL5RA Recombinant Antibody

产品编号

YR1226

别名

科研级 Benralizumab ( 苯拉组单抗 ), Anti-IL5RA Recombinant Antibody, Research Grade Benralizumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Benralizumab ( 苯拉组单抗 ), Anti-IL5RA Recombinant Antibody, Research Grade Benralizumab
Catalog Number	YR1226
Molecular Name	Benralizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody medication which is developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125). Two phase III clinical trials of benralizumab reported meeting their primary endpoints in 2016. It was approved by the US Food and Drug Administration in November 2017 for the treatment of severe eosinophilic asthma.
CAS Number	1044511-01-4
Application	WB, FCM, IP, ELISA, Neut, FuncS, IF
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	IL5RA[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0